Adhd and Abnormal behavior
Summary:
Abnormal behavior is found among people with Adhd, especially for people who are male, 2-9 old.
The study analyzes which people have Abnormal behavior with Adhd. It is created by eHealthMe based on reports of 2,683 people who have Adhd from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Adhd?
Adhd (adhd-mental disorders that develop in children) is found to be associated with 607 drugs and 1,371 conditions by eHealthMe. Check the latest studies of Adhd.
What is Abnormal behavior?
Abnormal behavior is found to be associated with 1,470 drugs and 1,870 conditions by eHealthMe. Check the latest studies of Abnormal behavior.
2,683 people who have Adhd and Abnormal Behavior are studied.

Gender of people who have Adhd and experienced Abnormal Behavior *:
- female: 24.79 %
- male: 75.21 %
Age of people who have Adhd and experienced Abnormal Behavior *:
- 0-1: 0.47000000000000003 %
- 2-9: 44.79 %
- 10-19: 41.91 %
- 20-29: 4.23 %
- 30-39: 3.58 %
- 40-49: 2.98 %
- 50-59: 1.72 %
- 60+: 0.28 %
Common co-existing conditions for these people *:
- Depression: 99 people, 3.69%
- Stress And Anxiety: 87 people, 3.24%
- Bipolar Disorder (mood disorder): 72 people, 2.68%
- Sleep Disorder: 51 people, 1.90%
- Insomnia (sleeplessness): 36 people, 1.34%
- Affective Disorder (mental disorder): 33 people, 1.23%
- Asthma: 32 people, 1.19%
- Autism Spectrum Disorder (developmental disabilities that can cause significant social, communication and behavioural challenges): 28 people, 1.04%
- Oppositional Defiant Disorder (a childhood disorder described by the diagnostic and statistical manual of mental disorders): 28 people, 1.04%
- Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 24 people, 0.89%
Common drugs taken by these people *:
- Strattera: 854 people, 31.83%
- Concerta: 316 people, 11.78%
- Daytrana: 304 people, 11.33%
- Vyvanse: 275 people, 10.25%
- Ritalin: 146 people, 5.44%
- Risperdal: 104 people, 3.88%
- Quillivant Xr: 96 people, 3.58%
- Intuniv: 76 people, 2.83%
- Adderall 10: 72 people, 2.68%
- Zoloft: 69 people, 2.57%
Common symptoms for these people *:
- Drug Ineffective: 560 people, 20.87%
- Aggression: 508 people, 18.93%
- Disturbance In Attention: 305 people, 11.37%
- Agitation (state of anxiety or nervous excitement): 271 people, 10.10%
- Irritability: 229 people, 8.54%
- Anger: 225 people, 8.39%
- Stress And Anxiety: 220 people, 8.20%
- Psychomotor Hyperactivity (feelings of extreme restlessness): 218 people, 8.13%
- Insomnia (sleeplessness): 214 people, 7.98%
- Drowsiness: 209 people, 7.79%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Abnormal behavior?
Check whether Abnormal behavior is associated with a drug or a conditionRelated publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Adhd (120,225 reports)
- Abnormal behavior (51,307 reports)
All the drugs that are associated with Abnormal behavior:
- Abnormal behavior (1,470 drugs)
All the conditions that are associated with Abnormal behavior:
- Abnormal behavior (1,870 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Abnormal behavior and Adhd, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Rocephin and Dexamethasone - now
- Drug interactions of Lyrica and Labetalol Hydrochloride - now
- Could Imitrex cause Abnormal Behavior? - now
- Could Micafungin Sodium cause Epstein-Barr Virus Infection? - now
- Headache and drugs of ingredients of lithium carbonate - 5 seconds ago
- Could Fioricet cause Abnormal Behavior? - 7 seconds ago
- Could Simvastatin cause Urethritis? - 9 seconds ago
- Could Aredia cause Weakness? - 10 seconds ago
- Dermatitis - Atopic and Anaemia - 11 seconds ago
- Could Solifenacin Succinate cause Dizziness? - 11 seconds ago